XTL BIOPHARMACEUTICALS LTD. Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss of $46.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss · last filed 2025-04-30
| Period end | Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss 12 month |
|---|---|
| 2024-12-31 | $46.00K 20-F · filed 2025-04-30 |
| 2023-12-31 | $144.00K 20-F · filed 2025-04-30 |
| 2022-12-31 | $152.00K 20-F · filed 2025-04-30 |